As of July 14, 2026, VYNE Therapeutics Inc. (VYNE) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. VYNE Therapeutics Inc. has a market capitalization of $22.74M, 33.35M shares outstanding, 46 institutional holders tracked. Key dilution vectors include 27.5K outstanding warrants, approximately 10 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split
65%
• 50-day avg $0.64 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market Cap$22.74M
Shares Outstanding33.35M
Float32.55M
Cash$24.93M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 74.6% shares (2026Q1 vs prior)
46 institutional holders · 14.73M shares
#1
Anson Funds Management LP
2.49M shares
#2
Nantahala Capital Management, LLC
2.00M shares
#3
Lynx1 Capital Management LP
1.63M shares
📉 Short Interest
Short Interest104.3K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2018
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for VYNE Shareholders
VYNE Therapeutics Inc. (VYNE) has a DilutionScore of 47/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
Cash runway is a key watch item: VYNE has approximately 10 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for VYNE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for VYNE alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track VYNE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VYNE — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for VYNE
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.